510(k) Report

FDA applicant

Neuravi, Ltd.

Galway, IE7 decisions2018–20250 recalls

FDA records 7 decisions for Neuravi, Ltd. (Galway, IE) from 2018 to 2025: 7 510(k) clearances. Most are in product codes NRY (Catheter, Thrombus Retriever) and QJP (Catheter, Percutaneous, Neurovasculature). Since 2016 its 510(k)s took a median of 127 days from receipt to decision, against 129 for FDA’s reviews in the same codes and years. Its devices cite 12 predicates, 8 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Neuravi Limited”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Neuravi, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2018: 12020: 12021: 32024: 12025: 1
2018high 3 (2021) · low 0 (2019)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2018.

FIG. 1 — Neuravi, Ltd. by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Neuravi, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report